Privia Health Group, Inc. 8-K

What Happened
Privia Health Group, Inc. (PRVA) filed an 8-K on May 22, 2026 reporting the results of its 2026 Annual Meeting of Stockholders, held via live webcast. Stockholders approved all three proposals: the election of three Class I directors (terms expiring at the 2029 Annual Meeting), an advisory (non-binding) approval of named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as the company's independent registered public accounting firm for fiscal 2026.

Key Details

• Directors elected (Class I, term expiring 2029):
  • Nancy Cocozza — 103,661,977 votes for; 2,213,903 withheld; 11,549,510 broker non-votes.
  • David King — 99,267,027 votes for; 6,608,853 withheld; 11,549,510 broker non-votes.
  • Francis Soistman — 105,602,389 votes for; 273,491 withheld; 11,549,510 broker non-votes.
• Advisory approval of executive compensation: 103,956,500 for; 1,813,934 against; 105,446 abstentions; 11,549,510 broker non-votes.
• Ratification of independent auditor (PwC) for 2026: 117,343,159 for; 8,578 against; 73,653 abstentions.
• Filing signed by David Mountcastle, EVP & CFO, on May 22, 2026.

Why It Matters
The outcomes confirm shareholder support for the current board slate and for the company’s executive compensation approach (advisory and non-binding). Ratifying PwC maintains continuity in external audit oversight for fiscal 2026. For investors, these votes signal governance stability and continuity in oversight—important context when assessing management and board accountability, though they do not directly change operations or financial results.